LisaAnnMahnkeMD

PubMed

• Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.
  Mahnke, L.A., Belshan, M., Ratner, L.> ;Virology. 2006 Apr 25
• Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex...
  Belshan, M., Mahnke, L.A., Ratner, L.> ;Virology. 2006 Mar 1
• Photo quiz. Chronic foot ulcers in a patient with hepatitis C.
  Mahnke, L., Groger, R.> ;Clin Infect Dis. 2005 May 1
• Tn5: A molecular window on transposition.
  Reznikoff, W. S., Bhasin, A., Davies, D. R., Goryshin, I. Y., Mahnke, L. A., Naumann, T., Rayment, I., Steiniger-White, M., Twining, S. S.> ;Biochem Biophys Res Commun. 1999 Dec 29
• Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.
  Wang, X., Boffito, M., Zhang, J., Chung, E., Zhu, L., Wu, Y., Patterson, K., Kashuba, A., Tebas, P., Child, M., Mahnke, L., Bertz, R.> ;AIDS Patient Care STDS. 2011 Sep
• The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
  Zhang, J., Chung, E., Yones, C., Persson, A., Mahnke, L., Eley, T., Xu, X., Bertz, R.> ;Antivir Ther (Lond). 2011
• Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.
  Zhu, L., Persson, A., Mahnke, L., Eley, T., Li, T., Xu, X., Agarwala, S., Dragone, J., Bertz, R.> ;J Clin Pharmacol. 2011 Mar
• Electrocardiographic changes in HIV-infected, drug experienced patients treated with atazanavir.
  Mahnke, L., Child, M., Satin, L., Persson, A., Bertz, R., Lawrence, J.> ;AIDS. 2008 Aug 20
• Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation.
  Mahnke, L., Clifford, D.> ;AIDS Res Ther. 2006
• Join now to see all